Enhancing the Efficacy of AAV Re-Administration in Liver Gene Therapy
Time: 2:45 pm
day: Pre-Conference Day
Details:
- Timing of immunosuppression is crucial to prevent immune activation towards AAV vector and transgene product
- Dose dependent effects on the efficacy of Immunosuppressive treatments
- Identification of the combination therapy for successful re-administration
